Parenteral Packaging Market Global Industry Share, Size, Growth, Demands, Revenue, Top Leaders And Growth Rate At 9% From 2021 To 2031
Future Market Insights (FMI) in its market analysis projects the parenteral packaging market to grow at 5.5% CAGR during the forecast period 2021-2031. Driven by the rising necessity of effective packaging solutions for therapeutic drugs without compromising their potency, the parenteral packaging market is forecast to reach the market valuation of US$ 11,460 Mn in 2021.
Manufacturers of parenteral packaging products are moving
away from the ‘drugs for container’ concept and are focusing on providing
‘containers for drugs’ – implying the adoption of appropriate materials to
manufacture parenteral containers.
The 3P’s driving the global parenteral packaging market are Product,
Process, and Patient, and given the increasing focus on sustainability and
green initiatives, plastic is slowly being eliminated from the parenteral
packaging ecosystem.
Companies are shifting towards prefilled and
ready-to-use containers and this is expected to augment the usability
of parenteral products in self-medication.
As such, the global market for parenteral packaging is set
to witness significant growth in the next 10 years, as estimated in a study by
Future Market Insights. According to a report released by the leading market
research firm, the global parenteral packaging market is set to exceed US$ 11460
Mn by the end of 2021.
Exhibiting a growth rate of 5.5% in the coming decade,
revenue from the sales of parenteral packaging products is slated to experience
around 6% year-on-year growth rate in 2021. Sustainability is the buzzword here
– manufacturers are steadfast in their focus on addressing environmental
concerns; which probably explains the near-death of plastic as a preferred
material for parenteral packaging, owing to environmental issues associated
with the disposal of plastic parenteral packaging products.
Competitive
Landscape:
Key players operating
in the global market for parenteral packaging include UFP Technologies, Inc.,
Schott AG, UDG Healthcare plc, Gerresheimer AG, Becton, Dickinson and Company,
Catalent, Inc., Stevanato Group S.p.A., Baxter International Inc., Nipro
Corporation, West Pharmaceutical Services, Inc., among others among others.
Innovation to Take
Centre Stage in the Manufacturing of Parenteral Packaging Products; Automation
to Underpin Core Production Processes
With technology having seeped through the global industry
fabric, the market for parenteral packaging products is witnessing a new era of
advanced processing techniques powered by automation in the packaging industry.
Advanced automation in manufacturing processes has brought
in notable modifications pertaining to the provision of drugs to patients, and
this integration of automation into core manufacturing systems is trending the
global parenteral packaging market.
Manufacturers are also focusing on deploying high quality,
contamination free processes to assemble parenteral packaging containers. These
processes seek to eliminate incidences of reactions between the material used
to manufacture the containers and the actual content (drugs) of the containers,
thereby preventing harmful effects on patients consuming the drugs.
Several product recalls in the past have forced
manufacturers of parenteral packaging products to select the best material to
manufacture containers, and this factor is acting in favour of revenue growth
of the global parenteral packaging market.
Ready-to-Fill Formats
and Automated Assembly Lines Trending the Global Parenteral Packaging Market
On the back of sustainability drives by global governments,
manufacturers of parenteral packaging products are changing their operations by
integrating automated systems in their assembly lines.
A strategic shift from manual to automatic packing lines is
bringing in enhanced process efficiency and reducing dependency on manual
labour, thereby creating pathways for cost-effectiveness in the long run.
Further, the rapidly rising demand for prefilled syringes is
benefitting the global parenteral packaging market.
Specific requirements from the healthcare industry for
speciality packaging products such as IV pre-mixed systems and single-use vials
is also expected to bolster revenue generation in the global market for
parenteral packaging in the coming years.
Newer Raw Material
Options to Create Increased Growth Opportunities for Manufacturers of
Parenteral Packaging Products
Over the years, conventional raw materials used to
manufacture parenteral packaging products have witnessed several advancements.
Add to this the introduction of newer types of material to manufacture
parenteral packaging containers, and the global market is suddenly a hotbed of
opportunities for manufacturers.
The global parenteral packaging market is witnessing
strategic collaboration between manufacturers and suppliers for both the
sourcing of appropriate raw materials and the final packaging formats.
For instance, polymers such as cyclic olefin polymers
(COP) and cyclic olefin copolymers (COC) are being sought after
in large numbers, owing to their inherent advantages over conventional plastic
and glass used to manufacture parenteral packaging containers.
The introduction of better raw material types supports
increased sophistication in drug delivery technologies, thereby helping
manufacturers up their revenue standing in the global market. Needless to say,
this is positively impacting revenue growth of the global parenteral packaging
market.
By Product Type:
·
Vials
·
Pre-filled Syringes & Cartridges
·
Bags
·
Ampoules
·
Ready to Use Systems
By Material Type:
·
Glass
·
Plastic
·
Polyvinyl Chloride (PVC)
·
Polyolefin
By Packaging Type:
·
Small Volume Parenteral (SVP)
·
Large Volume Parenteral (LVP)
Region:
·
North America
·
Western Europe
·
Eastern Europe
·
APEJ
·
Japan
·
MEA
To know more click here @ https://www.futuremarketinsights.com/reports/parenteral-packaging-market
Comments
Post a Comment